OSC-3 - Systemic Manifestations of Oral Disease and Oral Manifestations of Systemic Disease/Drug Related Osteonecrosis

Invited Speaker(s)

• 

  Cesar Migliorati, D.D.S., M.S., PhD

  Associate Dean of Clinical Affairs and Quality Assurance / Professor of Oral Medicine Department of Oral and Maxillofacial Diagnostic Sciences
  University of Florida College of Dentistry

  Disclosures: Amgen, Inc: Consultant, Honorarium; Colgate/Palmolive: Consultant, Honorarium

Session Host(s)

• NC

  Nauman Chatha

We will discuss the importance of evaluating and treating patients as a whole person. A large number of our patients have medical compromise that could require modification of dental care. Focus will be placed on cancer patients and how cancer therapies can affect the oral cavity. Oral complications observed during cancer treatment will be presented and diagnosis and management will be discussed. Several new anticancer drugs are being introduced and new oral complications are being diagnosed. Emphasis will be on osteonecrosis of the jaw (ONJ) including the way to diagnose and manage this complication. Jaw pain in patients taking antiresorptives may mimic toothache, leading to endodontic treatment. The persistence of symptoms after endodontic therapy frustrate patients and professionals.

Learning Objectives:

• Upon completion, participants will be able to conduct an evaluation of cancer patients and describe common oral complications of cancer therapies.
• At conclusion, participants should be able to recognize and define osteonecrosis of the jaw (ONJ) using clinical signs and symptoms that may be present with this oral complication.
• At conclusion, participants will be able to describe stages of ONJ and recommended management protocols, including possible indication for endodontic therapy.